Genetic assessments of AD risk factors also demonstrate inflammation as a potential first step in AD pathophysiology. Apolipoprotein E4 (APOE4) is closely tied to innate immunity and remains the strongest known risk factor for sporadic, late-onset AD [6]. This evidence concerns the gene APOE and Alzheimer disease.